CryoLife Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artivion Inc (AORT)
Artivion Inc stock price live, this page displays NYSE AORT stock exchange data. View the AORT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Artivion Inc real time stock price chart below.
What Is the Artivion Inc Stock Price Today?
The Artivion Inc stock price today is 37.16.
What Is the Stock Symbol for Artivion Inc?
The stock symbol for Artivion Inc is "AORT."
What Stock Exchange Does Artivion Inc Trade On?
Artivion Inc is listed and trades on the NYSE stock exchange.
Is Artivion Inc a Good Stock to Buy?
Determining whether Artivion Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AORT quote. (ISIN: US2289031005)
What Is the Artivion Inc Stock Price Today?
The Artivion Inc stock price today is 37.16.
What Is the Stock Symbol for Artivion Inc?
The stock symbol for Artivion Inc is "AORT."
What Stock Exchange Does Artivion Inc Trade On?
Artivion Inc is listed and trades on the NYSE stock exchange.
Is Artivion Inc a Good Stock to Buy?
Determining whether Artivion Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AORT quote. (ISIN: US2289031005)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.66
37.66
52 wk Range
23.04
48.25
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
36.6637.66
52 wk Range
23.0448.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AORT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
51.57
Upside
+38.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- CryoLife Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CryoLife Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- CryoLife Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CryoLife Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.
Artivion Inc Earnings Call Summary for Q4/2025
- Artivion exceeded Q4 2025 EPS expectations by 183.33% ($0.17 vs $0.06 forecast), driving a 1.36% stock increase to $40.55 despite slightly missing revenue targets.
- Q4 revenue grew 18.5% year-over-year to $118.3M, with stent grafts and On-X heart valves showing exceptional growth of 36% and 24% respectively.
- Adjusted EBITDA reached $22.7M (up 29% YoY) with a 19.2% margin for Q4 and 20.2% for the full year, generating positive free cash flow of approximately $1M for 2025.
- Management projects 10-14% revenue growth for 2026 ($486-504M), with continued strength in On-X and stent graft segments expected at mid-teens and low twenties growth rates.
- CEO Pat Mackin described 2025 as 'a standout year,' noting they're 'in the first inning' regarding market opportunity for their Ascending Aortic Dissection Solution (AMDS).
Last Updated: 2026-02-12, 05:44 p/m
Read Full TranscriptCompare AORT to Peers and Sector
Metrics to compare | AORT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAORTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 184.7x | 15.0x | −0.4x | |
PEG Ratio | 1.11 | 0.65 | 0.00 | |
Price/Book | 4.0x | 1.9x | 2.6x | |
Price / LTM Sales | 4.1x | 1.7x | 3.2x | |
Upside (Analyst Target) | 43.1% | 53.5% | 46.7% | |
Fair Value Upside | Unlock | 16.6% | 7.6% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 51.57
(+38.78% Upside)
Earnings
Latest Release
Feb 12, 2026
EPS / Forecast
0.17 / 0.06
Revenue / Forecast
116M / 116.42M
People Also Watch
FAQ
What Is the Artivion (AORT) Stock Price Today?
The Artivion stock price today is 37.16 USD.
What Stock Exchange Does Artivion Trade On?
Artivion is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Artivion?
The stock symbol for Artivion is "AORT."
What Is the Artivion Market Cap?
As of today, Artivion market cap is 1.80B USD.
What Is Artivion's Earnings Per Share (TTM)?
The Artivion EPS (TTM) is 0.21.
When Is the Next Artivion Earnings Date?
Artivion will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is AORT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Artivion Stock Split?
Artivion has split 2 times.
How Many Employees Does Artivion Have?
Artivion has 1800 employees.
What is the current trading status of Artivion (AORT)?
As of Apr 24, 2026, Artivion (AORT) is trading at a price of 37.16 USD, with a previous close of 37.03 USD. The stock has fluctuated within a day range of 36.66 USD to 37.66 USD, while its 52-week range spans from 23.04 USD to 48.25 USD.
What Is Artivion (AORT) Price Target According to Analysts?
The average 12-month price target for Artivion is 51.57 USD, with a high estimate of 58 USD and a low estimate of 42 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +38.78% Upside potential.
What Is the AORT After Hours Price?
AORT's last after hours stock price is 37.16 USD, the stock has decreased by -0.01, or -0.01%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.